The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases

[1]  C. Sima,et al.  Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes. , 2016, Clinical lung cancer.

[2]  D. Nonaka,et al.  Diagnostic Utility of Orthopedia Homeobox (OTP) in Pulmonary Carcinoid Tumors , 2016, The American journal of surgical pathology.

[3]  H. Groen,et al.  A Population‐Based Analysis of Application of WHO Nomenclature in Pathology Reports of Pulmonary Neuroendocrine Tumors , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  G. Giaccone,et al.  Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes? , 2022 .

[5]  N. Socci,et al.  Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets , 2016, Clinical Cancer Research.

[6]  James C Yao,et al.  Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study , 2016, The Lancet.

[7]  A. Nicholson,et al.  Testing for Neuroendocrine Immunohistochemical Markers Should Not Be Performed in Poorly Differentiated NSCCs in the Absence of Neuroendocrine Morphologic Features according to the 2015 WHO Classification. , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  H. Groen,et al.  Clinical features of large cell neuroendocrine carcinoma: a population-based overview , 2015, European Respiratory Journal.

[9]  G. Pelosi,et al.  What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms? , 2015, Seminars in diagnostic pathology.

[10]  A. Marchevsky,et al.  Diagnostic difficulties with the diagnosis of small cell carcinoma of the lung. , 2015, Seminars in diagnostic pathology.

[11]  A. Marchevsky,et al.  Neuroendocrine neoplasms of the lung: Concepts and terminology. , 2015, Seminars in diagnostic pathology.

[12]  R. Wirtz,et al.  Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms , 2015, Histopathology.

[13]  John M S Bartlett,et al.  An international study to increase concordance in Ki67 scoring , 2015, Modern Pathology.

[14]  R. Wirtz,et al.  Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers. , 2015, The Journal of clinical endocrinology and metabolism.

[15]  W. Travis.  WHO classification of tumours of the lung, pleura, thymus and heart , 2015 .

[16]  A. Nicholson,et al.  Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  M. Rubin,et al.  Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation , 2014, The American journal of surgical pathology.

[18]  W. Travis,et al.  Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical Practice , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[19]  A. Nicholson,et al.  BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas , 2014, Histopathology.

[20]  G. Pelosi,et al.  Grading the neuroendocrine tumors of the lung: an evidence-based proposal. , 2013, Endocrine-related cancer.

[21]  John M S Bartlett,et al.  An international Ki67 reproducibility study. , 2013, Journal of the National Cancer Institute.

[22]  D. Ettinger,et al.  Utility of the Quantitative Ki-67 Proliferation Index and CD56 Together in the Cytologic Diagnosis of Small Cell Lung Carcinoma and Other Lung Neuroendocrine Tumors , 2013, Acta Cytologica.

[23]  Otto S Hoekstra,et al.  Clinicians are right not to like Cohen’s κ , 2013, BMJ : British Medical Journal.

[24]  E. Thunnissen,et al.  CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids , 2013, Clinical Cancer Research.

[25]  G. Kayser,et al.  Simultaneous Multi-Antibody Staining in Non-Small Cell Lung Cancer Strengthens Diagnostic Accuracy Especially in Small Tissue Samples , 2013, PloS one.

[26]  D. Kuik,et al.  Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma , 2012, Virchows Archiv.

[27]  G. Pelosi,et al.  A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples. , 2012, Anticancer research.

[28]  W. Kim,et al.  Interobserver Variability in Diagnosing High-Grade Neuroendocrine Carcinoma of the Lung and Comparing It with the Morphometric Analysis , 2012, Korean journal of pathology.

[29]  W. Hanna,et al.  Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma. , 2011, American journal of clinical pathology.

[30]  J. Mandrekar.  Measures of interrater agreement. , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  B. Skov,et al.  ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung: Distribution and Impact on Survival , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[32]  M. D. den Bakker,et al.  Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability , 2010, Histopathology.

[33]  Toshihide Matsumoto,et al.  Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas , 2010, Pathology international.

[34]  T. Nakajima,et al.  High‐grade neuroendocrine carcinoma of the lung: Comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma , 2009, Pathology international.

[35]  M. Nucci,et al.  Biomarker‐assisted diagnosis of ovarian, cervical and pulmonary small cell carcinomas: the role of TTF‐1, WT‐1 and HPV analysis , 2007, Histopathology.

[36]  Takehiko Fujisawa,et al.  Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis , 2006, Modern Pathology.

[37]  H. Kato,et al.  Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel. , 2006, American journal of clinical pathology.

[38]  A. Nicholson,et al.  CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact , 2005, Journal of Clinical Pathology.

[39]  A. Saqi,et al.  Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. , 2005, American journal of clinical pathology.

[40]  T. Nakajima,et al.  Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma. , 2005, Lung cancer.

[41]  G. Pelosi,et al.  Typical and Atypical Pulmonary Carcinoid Tumor Overdiagnosed as Small-Cell Carcinoma on Biopsy Specimens: A Major Pitfall in the Management of Lung Cancer Patients , 2005, The American journal of surgical pathology.

[42]  D. Zander,et al.  Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach , 2005, Modern Pathology.

[43]  A. Gown,et al.  p63 Expression in Lung Carcinoma: A Tissue Microarray Study of 408 Cases , 2004, Applied immunohistochemistry & molecular morphology : AIMM.

[44]  A. Nicholson,et al.  TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. , 2004, Human pathology.

[45]  M. Leversha,et al.  Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays , 2003, The Journal of pathology.

[46]  D. Burstein,et al.  p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. , 2003, American journal of clinical pathology.

[47]  A. Marchevsky,et al.  Morphometry confirms the presence of considerable nuclear size overlap between "small cells" and "large cells" in high-grade pulmonary neuroendocrine neoplasms. , 2001, American journal of clinical pathology.

[48]  R. Lloyd,et al.  Thyroid Transcription Factor-1 Distinguishes Metastatic Pulmonary From Well-Differentiated Neuroendocrine Tumors of Other Sites , 2001, The American journal of surgical pathology.

[49]  W. Benedict,et al.  Differential retinoblastoma and p16INK4A protein expression in neuroendocrine tumors of the lung , 2000, Cancer.

[50]  A. Scharl,et al.  Expression of p16 and lack of pRB in primary small cell lung cancer , 1999, The Journal of pathology.

[51]  J. Minna,et al.  Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  W. Travis,et al.  Reproducibility of neuroendocrine lung tumor classification. , 1998, Human pathology.

[53]  H. Matsuda,et al.  Inversely correlated expression of p16 and Rb protein in non‐small cell lung cancers: An immunohistochemical study , 1996, International journal of cancer.

[54]  C. D. Edwards,et al.  Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. , 1995, Cancer research.

[55]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[56]  J. Peterse,et al.  Reliability of Fine Needle Aspiration Cytology For Distinguishing Between Carcinoma, Lymphoma and Sarcoma; the Influence of Clinical Information , 1993, Cytopathology : official journal of the British Society for Clinical Cytology.

[57]  W Schaafsma,et al.  Further evaluation of quantitative nuclear image features for classification of lung carcinomas. , 1992, Pathology, research and practice.

[58]  A. Marchevsky,et al.  Problems in the diagnosis of small cell carcinoma of the lungs by fiberoptic bronchoscopy. , 1984, Cancer detection and prevention.

[59]  R. Vollmer.  The effect of cell size on the pathologic diagnosis of small and large cell carcinomas of the lung , 1982, Cancer.